Only open-market buys / sells (codes P/S) are a conviction signal; grants, option exercises, tax-withholding, and gifts are compensation mechanics, shown but greyed. The trailing 12-month tallies run to today but the store covers filings through 2026-06-30 only (SEC bulk data sets publish quarterly), so recent activity may be absent.
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-16 | Ambrose Allison | Officer | −Sell | 477 | $6.10 | $2,910 |
| 2026-06-16 | Deykin Aaron | Officer | −Sell | 895 | $6.10 | $5,460 |
| 2026-06-16 | Houghton Adam | Officer | −Sell | 700 | $6.10 | $4,270 |
| 2026-06-16 | Sutherland Everett Rand | Director,Officer | −Sell | 2,095 | $6.10 | $12,780 |
| 2026-06-16 | GRAY MICHAEL | Officer | −Sell | 853 | $6.10 | $5,203 |
| 2026-03-16 | Houghton Adam | Officer | −Sell | 699 | $9.29 | $6,494 |
| 2026-03-16 | Ambrose Allison | Officer | −Sell | 475 | $9.29 | $4,413 |
| 2026-03-16 | Sutherland Everett Rand | Director,Officer | −Sell | 2,093 | $9.29 | $19,444 |
| 2026-03-16 | Deykin Aaron | Officer | −Sell | 894 | $9.29 | $8,305 |
| 2026-03-16 | GRAY MICHAEL | Officer | −Sell | 852 | $9.29 | $7,915 |
| 2026-01-02 | Sutherland Everett Rand | Director,Officer | +Grant | 75,000 | — | — |
| 2026-01-02 | Houghton Adam | Officer | +Grant | 25,000 | — | — |
| 2026-01-02 | Ambrose Allison | Officer | +Grant | 17,000 | — | — |
| 2026-01-02 | Deykin Aaron | Officer | +Grant | 32,000 | — | — |
| 2026-01-02 | GRAY MICHAEL | Officer | +Grant | 30,500 | — | — |
| 2024-10-15 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | TenPercentOwner | +Conversion | 894,733 | — | — |
| 2024-10-15 | Access Industries Holdings LLC | TenPercentOwner | +Conversion | 1,172,410 | — | — |
| 2024-10-15 | Access Industries Holdings LLC | TenPercentOwner | +Conversion | 3,147,000 | — | — |
| 2024-10-15 | Access Industries Holdings LLC | TenPercentOwner | +Buy | 1,175,000 | $17.00 | $20M |
| 2024-10-15 | ORBIMED ADVISORS LLC | Director,TenPercentOwner | +Buy | 660,000 | $17.00 | $11M |
| 2024-10-15 | ORBIMED ADVISORS LLC | Director,TenPercentOwner | +Conversion | 721,956 | — | — |
| 2024-10-15 | ORBIMED ADVISORS LLC | Director,TenPercentOwner | +Buy | 165,000 | $17.00 | $3M |
| 2024-10-15 | ORBIMED ADVISORS LLC | Director,TenPercentOwner | +Conversion | 2,887,833 | — | — |
| 2024-10-15 | Chimovits Erez | Director,TenPercentOwner | +Buy | 660,000 | $17.00 | $11M |
| 2024-10-15 | Chimovits Erez | Director,TenPercentOwner | +Conversion | 2,887,833 | — | — |
| 2024-10-15 | Chimovits Erez | Director,TenPercentOwner | +Buy | 165,000 | $17.00 | $3M |
| 2024-10-15 | Chimovits Erez | Director,TenPercentOwner | +Conversion | 721,956 | — | — |
Source: the SEC bulk insider (Form 3/4/5) data sets — non-derivative transactions in the issuer's common stock, most recent first, covering filings through 2026-06-30. Insiders file within 2 business days of a transaction, but the bulk sets publish quarterly, so this store lags live filings; option/derivative lines are excluded. Codes: P buy · S sell · A grant · M/X/C exercise · F tax · G gift.
Model-derived estimate for research. See the Disclaimer.
